Does SoftBank have 20 more DoorDashes?

Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. Natasha and Danny and Alex and Grace were all here to chat through the week’s biggest tech happenings. This week felt oddly comforting from a tech news perspective: Facebook is copying something, early-stage startup data is flawed enough to talk about and sweet DoorDash […]

Read More

TechCrunch’s favorites from Techstars’ Boston, Chicago and workforce accelerators

Building off TechCrunch’s coverage of the recent 500 Startups demo day, we’re back today to talk about some favorites from three more accelerator classes. This time we’re digging into Techstars’ latest three accelerator classes. What follows are four favorites from the Techstars’ Boston, Chicago and “workforce development” programs. As a team we tuned into the accelerator […]

Read More

South African VC firm Knife Capital gets first commitment for its $50M fund, to invest in 10-12 Series B rounds

Knife Capital, a South African venture capital firm, is raising a $50 million fund for startups looking to raise Series B financing. With Knife Fund III called the African Series B Expansion Fund, the firm seeks to directly invest in the aggressive expansion of South African breakout companies. It also plans to co-invest in companies […]

Read More

A Dallas-based founder looks to tackle the student loan crisis with his startup, College Cash

Demetrius Curry has spent the last couple years chasing a dream. His startup, College Cash, allows brands to petition users to create photo and video marketing content highlighting their product or service, with the wrinkle being that content creators are paid by the brands in the form of credits that go directly toward paying down […]

Read More

Immunai raises $60M as it expands from improving immune therapies to discovering new ones, too

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has already established the largest database in the world for single cell immunity characteristics, and it has already used its machine learning-powered immunity analysts platform to […]

Read More